arXiv:2607.25322cs.AI2026-07

通过解耦药物机制与模态噪声,实现零样本药物属性预测

From Cellular Responses to Pharmacological Domains: Multimodal Zero-Shot Drug Representation Learning

论文配图:From Cellular Responses to Pharmacological Domains: Multimodal Zero-Shot Drug Representation Learning
图 1 · 摘自论文原文
  • 分离药物机制信号与模态特有噪声,构建跨三模态共识响应域
  • 在多个公开数据集上实现更优的零样本药物属性预测性能
  • 适合需要机制可解释性的药物发现研究者使用

多模态药物发现通过整合基因表达、细胞形态等细胞响应信息,突破化学结构限制进行药物表征学习。然而,直接融合与实例级对比对齐会混淆机制相关信号与模态特异性噪声,并错误分离结构不同但生物学相关的化合物,掩盖转移性机制模式,影响未见化合物性质预测。本文提出PMRD框架,通过药理响应域引导的多模态零样本药物属性预测,分离机制一致因子与模态特异性信息,构建三模态共识响应域。机制候选增强识别局部稳定因子,检索-几何归因动态重加权对齐与增强目标,依据更新是否保持药物间可区分性进行反馈,抑制与机制可区分性冲突的训练信号。PMRD进一步通过可靠性感知的多视图检索融合互补表示。实验表明,在多个公开数据集上,模型提升零样本属性预测性能,生成更具生物学一致性的药物邻域。硬负例分析显示,结构差异大但响应相关的化合物间冲突减少。结果验证了PMRD在机制感知的多模态药物表征学习中的有效性。

原文摘要 · Abstract (English)

Multimodal drug discovery enables drug representation learning beyond chemical structure by incorporating cellular responses such as gene expression and cell morphology. However, direct fusion and instance-level contrastive alignment may mix mechanism-related signals with modality-specific noise and incorrectly separate structurally dissimilar but biologically related compounds. This limitation can obscure transferable mechanism patterns required for predicting the properties of unseen compounds. We introduce PMRD, a pharmacological response domain-guided framework for multimodal zero-shot drug property prediction. PMRD separates mechanism-consistent factors from modality-specific information and constructs a consensus response domain across three modalities. Mechanism candidate augmentation identifies locally stable factors, while retrieval-geometry attribution dynamically reweights the alignment and augmentation objectives according to whether their updates preserve inter-drug discriminability.This feedback suppresses training signals that conflict with mechanism-discriminative retrieval. PMRD further combines complementary representations through reliability-aware multiview retrieval. Experiments on public datasets show improved zero-shot property prediction and more biologically coherent drug neighborhoods. Hard-negative analysis further indicates fewer conflicts between structurally dissimilar but response-related compounds. These results support PMRD as an effective framework for mechanism-aware multimodal drug representation learning.\footnote{The code will be released upon publication.}

药物发现多模态学习零样本预测机制可解释

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。